TABLE 2.
Linear regression associations of HAM-A score with LVMI and Tp–Te/QT ratio.
| Model 1* |
Model 2† |
Model 3‡ |
||||
| β (95% CI) | P value | β (95% CI) | P value | β (95% CI) | P value | |
| LVMI | 2.24 (1.88–2.61) | <0.001 | 2.33 (1.97–2.69) | <0.001 | 2.13 (1.77–2.49) | <0.001 |
| Tp–Te/QT | 0.002 (0.001–0.002) | <0.001 | 0.002 (0.001–0.003) | <0.001 | 0.001 (0.000–0.002)§ | 0.013 |
*Model 1: unadjusted.
†Model 2: adjusted for age, gender, body mass index, cigarette smoking.
‡Model 3: adjusted for age, gender, body mass index, cigarette smoking, creatinine, uric acid, total cholesterol, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, ACEI/ARB, β blockers, and calcium channel blockers.
§Adjusted for Model 3 plus LVH.
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CI, confidence interval; HAM-A, Hamilton anxiety scale; LVH, left ventricular hypertrophy; LVMI, left ventricular mass index; OR, odds ratio; QT interval, Q wave start to T wave end interval; Tp–Te interval, T-wave peak to T-wave end interval.